Journal: Scientific Reports
Article Title: Modified lipid metabolism and cytosolic phospholipase A2 activation in mesangial cells under pro-inflammatory conditions
doi: 10.1038/s41598-022-10907-4
Figure Lengend Snippet: Signaling pathway overview. Hyperglycemia stimulates mesangial production of IL-1β which activates PDGF-BB secretion. In turn, PDGF-BB promotes IL-1β secretion, sustaining and boosting the pathway activation. IL-1β and PDGF-BB stimulation give rise to the production of phosphorylated sphingoid bases, activating COX-2 transcription. At the same time, IL-1β and PDGF-BB stimulate cPLA2 activation. Arachidonic acid (AA) released by cPLA2 is converted into prostanoids by COX-2 and downstream enzymes. The other product of cPLA2, lysophosphatidylcholine (LPC), is converted into lysophosphatidic acid (LPA) by autotaxin. Thus, hyperglycemia triggered the activation of an interplay between IL-1β and PDGF-BB which stimulates the secretion of lipid hormones (prostanoids PGE2, PGI2, but also lysophosphatidic acid) with hemodynamic, proliferative, and migratory effects at glomerular level. Inhibition of the cPLA2 reaction with AACOCF3 blocks the supply of AA for the COX-2 reaction, thus resolving the inflammatory stimulus. In addition, LPC is not produced, and this blocks the supply for the autotaxin reaction and LPA mediated proliferative response.
Article Snippet: The following antibodies were used: anti-Phospho-cPLA2 #53044 (Ser505) and anti-total cPLA2 #2831 (Cell Signaling technology, Danvers, MA), used at a 1:500 v/v dilution in TBST 5% BSA; anti-Sphk1 #12071, anti-NLRP3 #15101, anti-IL-1β #12703, anti-COX-2 #4842 (Cell Signaling technology) used at a 1:500 v/v dilution in 5% milk; finally, anti-Cerk #HPA064699 (Sigma Aldrich), used at a 1:1000 v/v dilution in TBST 5% milk.
Techniques: Activation Assay, Inhibition, Produced